Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension
A. Parpaleix (Creteil, France), S. Abid (Creteil, France), E. Marcos (Creteil, France), V. Amsellem (Creteil, France), A. Houssaïni (Creteil, France), M. Breau (Creteil, France), D. Sawaki (Creteil, France), E. Bizard (Creteil, France), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), L. Lipskaia (Creteil, France), S. Adnot (Creteil, France)
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Session: Experimental research in pulmonary hypertension
Session type: Thematic Poster
Number: 3066
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Parpaleix (Creteil, France), S. Abid (Creteil, France), E. Marcos (Creteil, France), V. Amsellem (Creteil, France), A. Houssaïni (Creteil, France), M. Breau (Creteil, France), D. Sawaki (Creteil, France), E. Bizard (Creteil, France), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), L. Lipskaia (Creteil, France), S. Adnot (Creteil, France). Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension. 3066
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: